Matches in Wikidata for { <http://www.wikidata.org/entity/Q66035483> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q66035483 description "clinical trial" @default.
- Q66035483 description "ensayu clínicu" @default.
- Q66035483 description "klinisch onderzoek" @default.
- Q66035483 description "клінічне випробування" @default.
- Q66035483 name "Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer" @default.
- Q66035483 name "Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer" @default.
- Q66035483 type Item @default.
- Q66035483 label "Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer" @default.
- Q66035483 label "Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer" @default.
- Q66035483 prefLabel "Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer" @default.
- Q66035483 prefLabel "Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer" @default.
- Q66035483 P1132 Q66035483-1428295C-7F25-4346-A84C-CF9C7A9A9AE5 @default.
- Q66035483 P1476 Q66035483-F9D6AB7A-DA7C-4A64-A9D1-E6B7508BEF01 @default.
- Q66035483 P17 Q66035483-9804F50B-97D6-489A-95CF-281B481DA61A @default.
- Q66035483 P17 Q66035483-BD28A5B8-52B2-435A-A951-FFDCAA10F7B2 @default.
- Q66035483 P17 Q66035483-C6DAFC8E-F31D-468D-80A9-643A54DFCAE7 @default.
- Q66035483 P2899 Q66035483-E6990A5F-4789-4745-A4C7-51CAFEA2F200 @default.
- Q66035483 P3098 Q66035483-FB3985C7-0E21-4AB5-9620-B72EE46D32A1 @default.
- Q66035483 P31 Q66035483-3BC55D11-90AE-4C5F-BCD6-EC6FD610EEBB @default.
- Q66035483 P580 Q66035483-E4399C3B-6871-4663-87D7-7137F2972A2F @default.
- Q66035483 P582 Q66035483-256679DA-DC3D-482E-B688-521BE4FCE8F1 @default.
- Q66035483 P6099 Q66035483-DA6DD70D-3E45-473E-BC1E-60BE1E77F9EF @default.
- Q66035483 P6153 Q66035483-22D4809D-597C-4148-B20E-020C4ABE0E71 @default.
- Q66035483 P8363 Q66035483-7737682A-D21F-4D37-A750-1A6BB83F7D55 @default.
- Q66035483 P859 Q66035483-34FE41A6-4C31-4EE3-8AE2-5C811F9C2CB1 @default.
- Q66035483 P1132 "+399" @default.
- Q66035483 P1476 "WEEKLY IV TOPOTECAN/DOCETAXEL COMBINATION COMPARED TO DOCETAXEL IN PATIENTS WITH PRETREATED ADVANCED NSCLC: AN OPEN-LABEL MULTICENTER RANDOMIZED PHASE III TRIAL" @default.
- Q66035483 P17 Q16 @default.
- Q66035483 P17 Q30 @default.
- Q66035483 P17 Q36 @default.
- Q66035483 P2899 "+18" @default.
- Q66035483 P3098 "NCT00065182" @default.
- Q66035483 P31 Q30612 @default.
- Q66035483 P580 "2003-08-14T00:00:00Z" @default.
- Q66035483 P582 "2007-08-30T00:00:00Z" @default.
- Q66035483 P6099 Q42824440 @default.
- Q66035483 P6153 Q212322 @default.
- Q66035483 P8363 Q78089383 @default.
- Q66035483 P859 Q212322 @default.